Published • loading... • Updated
Injectable Drug Helps Asthma Patients Clear Mucus-Clogged Airways
- An anti-inflammation injectable drug called Dupilumab improves breathing among asthma patients, according to a new clinical trial.
- The trial found that only 33% of patients on Dupilumab had mucus severely plugging their airways by the end, down from 67% at the start.
- Dupilumab reduces mucus plugging and airway inflammation as early as four weeks after treatment initiation.
- Patients with moderate-to-severe asthma should consult their doctor about using Dupilumab to clear mucus more effectively.
Insights by Ground AI
23 Articles
23 Articles
+20 Reposted by 20 other sources
Injectable Drug Helps Asthma Patients Clear Mucus-Clogged Airways
Key Takeaways
Coverage Details
Total News Sources23
Leaning Left5Leaning Right4Center6Last UpdatedBias Distribution40% Center
Bias Distribution
- 40% of the sources are Center
40% Center
L 33%
C 40%
R 27%
Factuality
To view factuality data please Upgrade to Premium


















